Baird Adjusts Quest Diagnostics' Price Target to $144 From $138
MT NewswiresApr 30 08:37 ET
Piper Sandler Reaffirms Their Hold Rating on Quest Diagnostics (DGX)
TipRanksApr 30 07:06 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Apellis Pharmaceuticals (APLS), Quest Diagnostics (DGX) and Healthcare Services (HCSG)
TipRanksApr 26 03:08 ET
Quest Diagnostics: A Hold Rating Amid Solid Earnings and Strategic Caution
TipRanksApr 26 02:15 ET
Quest Diagnostics Analyst Ratings
BenzingaApr 25 14:35 ET
Barclays Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $144
BenzingaApr 25 14:36 ET
UBS Adjusts Price Target on Quest Diagnostics to $146 From $139, Maintains Neutral Rating
MT NewswiresApr 24 09:48 ET
Quest Diagnostics Analyst Ratings
BenzingaApr 24 07:52 ET
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Tactile Systems Technology (TCMD) and Danaher (DHR)
TipRanksApr 24 07:20 ET
Evercore ISI Raises Quest Diagnostics Price Target to $145 From $140
MT NewswiresApr 23 14:16 ET
Quest Diagnostics: Strong Q1 Outperformance Spurs Buy Rating and Raised Full-Year Guidance
TipRanksApr 23 09:37 ET
Barclays Remains a Hold on Quest Diagnostics (DGX)
TipRanksApr 16 05:57 ET
Quest Diagnostics Analyst Ratings
BenzingaMar 20 11:50 ET
Truist Financial Sticks to Their Hold Rating for Quest Diagnostics (DGX)
TipRanksMar 20 07:15 ET
Leerink Partners Initiates Coverage On Quest Diagnostics With Market Perform Rating, Announces Price Target of $135
BenzingaFeb 26 09:17 ET
Quest Diagnostics Analyst Ratings
BenzingaFeb 26 09:15 ET
Piper Sandler Remains a Hold on Quest Diagnostics (DGX)
TipRanksFeb 8 07:38 ET
Jefferies Upgrades Quest to Buy, Sees 2024 Guidance as Conservative
Seeking AlphaFeb 7 13:00 ET
Jefferies Upgrades Quest Diagnostics to Buy From Hold, Adjusts Price Target to $155 From $140
MT NewswiresFeb 7 12:50 ET
Jefferies Upgrades Quest Diagnostics to Buy, Raises Price Target to $155
BenzingaFeb 7 06:23 ET
No Data
No Data